Animal Drug User Fee Act; Public Meeting; Request for Comments
Details
The document's own metadata, straight from the source system.
- Title
- Animal Drug User Fee Act; Public Meeting; Request for Comments
- Posted
- Apr 17, 2026
- Comment period
- Apr 17, 2026 – Dec 2, 2027
- FR Doc
- 2026-07498
- Topics
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Choose up to five.
| Organization | Adufa reauthorization | Modernization of animal drug review |
|---|
2 organization-typed comments could not be identified.
Campaigns
Organized form-letter drives, separated from organic one-off comments.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Jul 1, 2026Comment from Association of Fish and Wildlife Agencies- Drug Approval Working GroupAnalysis pending📎 AttachmentRead comment →
- Jun 30, 2026Comment from National Aquaculture AssociationAnalysis pending📎 AttachmentRead comment →
- Jun 30, 2026Comment from Food Animal Concerns TrustAnalysis pending📎 AttachmentRead comment →
- Jun 25, 2026Comment from National Cattlemen's Beef AssociationAnalysis pending📎 AttachmentRead comment →
- Jun 24, 2026Comment from Ware JodiOpposeIndividual
The commenter opposes the current structure of the Animal Drug User Fee Act (ADUFA) because it focuses on pre-market review rather than post-marketing surveillance and compliance. They argue that the FDA lacks sufficient authorities to manage safety risks after a drug is on the market and call for stronger oversight and safeguards to protect human and animal health.
Read comment → - Jun 24, 2026Comment from Tibensky JamesSupportIndividual
An individual commenter supports the proposed action by urging the FDA to seek greater authority from Congress to address antibiotic resistance and public health risks associated with veterinary drugs in food animals.
Read comment → - Jun 22, 2026Comment from Duda Timothy EdwardSupportIndividual
The commenter supports the proposed action by advocating for stronger FDA oversight and data collection regarding antibiotic use on large-scale livestock and poultry facilities. They argue that the FDA should seek Congressional authority to monitor and prohibit the overuse of antibiotics to combat antibiotic resistance.
Read comment → - Jun 22, 2026Comment from Hlodnicki BruceSupportIndividual
The commenter supports the reauthorization of the Animal Drug User Fee Act (ADUFA) but argues that the FDA must be granted greater authority to address antibiotic resistance. They specifically advocate for the power to require label changes when certain uses of animal drugs pose public health risks.
Read comment → - Jun 22, 2026Comment from Doyle KathleenSupportIndividual
The commenter supports the FDA taking action to combat antibiotic resistance by requesting that Congress grant the agency the authority to collect data on antibiotic use at large livestock and poultry facilities. They also advocate for the FDA to seek the power to prohibit the overuse of antibiotics on these large-scale factory farms.
Read comment → - Jun 22, 2026Comment from Bower RogerSupportIndividual
The commenter supports the proposed action by advocating for stronger FDA oversight and data collection regarding antibiotic use in large-scale livestock and poultry facilities. They argue that the FDA should seek congressional authority to monitor and prohibit the overuse of antibiotics on factory farms to combat antibiotic resistance.
Read comment →